Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04479072 · ClinicalTrials.gov registry record · Phase 4
Aspirin and Preeclampsia
A Phase 4 study of Preeclampsia Postpartum, sponsored by University of Chicago.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT04479072 is a Phase 4 study of Preeclampsia Postpartum that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 180 participants, above the 52-participant average among 8 other Preeclampsia Postpartum trials with a reported enrollment target (246% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04479072, a Phase 4 study of Preeclampsia Postpartum, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center, double-blind, randomized, placebo-controlled clinical trial. Peripartum and postpartum Activin A are significantly elevated in women with preeclampsia. Our hypothesis is that elevated Activin A levels reflect a remediable signal and that reducing postpartum Activin A levels with aspirin therapy will improve (GLS) in preeclamptic patients.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Aspirin 81 mg
Study Locations (1)
Illinois
- University of Chicago Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2021-02-15 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04479072
The ClinicalTrials.gov registry entry for NCT04479072 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 52-participant average among 8 other Preeclampsia Postpartum trials with a reported enrollment target (246% higher). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Preeclampsia Postpartum appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04479072 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT04479072 about?
NCT04479072 is a clinical study titled "Aspirin and Preeclampsia". This is a single-center, double-blind, randomized, placebo-controlled clinical trial. Peripartum and postpartum Activin A are significantly elevated in women with preeclampsia. Our hypothesis is that elevated Activin A levels reflect a remediable signal and that reducing postpartum Activin A levels ...
What is the current status of trial NCT04479072?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 180 participants. The study started on 2021-02-15. Estimated completion is 2026-12-31.
What conditions does trial NCT04479072 study?
This clinical trial studies the following conditions: Preeclampsia Postpartum.
What interventions are being tested in trial NCT04479072?
The interventions under investigation include: Placebo (DRUG), Aspirin 81 mg (DRUG).
Who is sponsoring clinical trial NCT04479072?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04479072 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia Postpartum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Aspirin for Postpartum Patients With Preeclampsia
RECRUITING · Phase 2
-
Postpartum Low-Dose Aspirin and Preeclampsia
RECRUITING · Phase 2
-
Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia
RECRUITING · Early Phase 1
-
Vascular Effects of High-Salt After Preeclampsia
RECRUITING · Early Phase 1
-
Preeclampsia Educational Program Study (PrEPS)
ACTIVE NOT RECRUITING · NA
-
MR and Inflammation After Preeclampsia
ACTIVE NOT RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.